Recent NYC Department of Health surveillance shows 18 confirmed West Nile neuroinvasive disease cases among city residents through mid-September 2026, alongside 1,737 positive mosquito pools—nearly double the prior year’s pace—with detections across all boroughs since June. This aligns with elevated regional activity and an early national surge, though city larviciding and control measures continue. Historical baselines indicate recent annual neuroinvasive averages of 16–31, with most cases typically reported by early fall and additional detections possible through October. Trader consensus favoring the 20–34 range reflects these trends plus uncertainty around final reporting lags and weather-driven transmission variability, while lower odds for under 20 or 50-plus outcomes track the current trajectory and typical seasonal patterns.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateHow many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
20 to 34 55%
35 to 49 27%
50 or more 8.1%
Fewer than 20 5.8%
$12,490 Vol.
$12,490 Vol.
Mar 31, 2027
Fewer than 20
6%
20 to 34
55%
35 to 49
27%
50 or more
8%
20 to 34 55%
35 to 49 27%
50 or more 8.1%
Fewer than 20 5.8%
$12,490 Vol.
$12,490 Vol.
Mar 31, 2027
Fewer than 20
$3,999 Vol.
6%
20 to 34
$5,110 Vol.
55%
35 to 49
$2,784 Vol.
27%
50 or more
$596 Vol.
8%
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.
Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.
The 2026 count shown on the source as of January 1, 2027 is the starting figure.
If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.
If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Recent NYC Department of Health surveillance shows 18 confirmed West Nile neuroinvasive disease cases among city residents through mid-September 2026, alongside 1,737 positive mosquito pools—nearly double the prior year’s pace—with detections across all boroughs since June. This aligns with elevated regional activity and an early national surge, though city larviciding and control measures continue. Historical baselines indicate recent annual neuroinvasive averages of 16–31, with most cases typically reported by early fall and additional detections possible through October. Trader consensus favoring the 20–34 range reflects these trends plus uncertainty around final reporting lags and weather-driven transmission variability, while lower odds for under 20 or 50-plus outcomes track the current trajectory and typical seasonal patterns.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.
Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.
The 2026 count shown on the source as of January 1, 2027 is the starting figure.
If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.
If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.
The 2026 count shown on the source as of January 1, 2027 is the starting figure.
If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.
If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Binuksan ang Market: Aug 20, 2026, 5:18 PM ET
Volume
$12,490Petsa ng Pagtatapos
Mar 31, 2027Binuksan ang Market
Aug 20, 2026, 5:18 PM ETResolver
0x69c47De9D...This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.
Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.
The 2026 count shown on the source as of January 1, 2027 is the starting figure.
If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.
If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Recent NYC Department of Health surveillance shows 18 confirmed West Nile neuroinvasive disease cases among city residents through mid-September 2026, alongside 1,737 positive mosquito pools—nearly double the prior year’s pace—with detections across all boroughs since June. This aligns with elevated regional activity and an early national surge, though city larviciding and control measures continue. Historical baselines indicate recent annual neuroinvasive averages of 16–31, with most cases typically reported by early fall and additional detections possible through October. Trader consensus favoring the 20–34 range reflects these trends plus uncertainty around final reporting lags and weather-driven transmission variability, while lower odds for under 20 or 50-plus outcomes track the current trajectory and typical seasonal patterns.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.
Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.
The 2026 count shown on the source as of January 1, 2027 is the starting figure.
If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.
If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.
The 2026 count shown on the source as of January 1, 2027 is the starting figure.
If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.
If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Volume
$12,490Petsa ng Pagtatapos
Mar 31, 2027Binuksan ang Market
Aug 20, 2026, 5:18 PM ETResolver
0x69c47De9D...Recent NYC Department of Health surveillance shows 18 confirmed West Nile neuroinvasive disease cases among city residents through mid-September 2026, alongside 1,737 positive mosquito pools—nearly double the prior year’s pace—with detections across all boroughs since June. This aligns with elevated regional activity and an early national surge, though city larviciding and control measures continue. Historical baselines indicate recent annual neuroinvasive averages of 16–31, with most cases typically reported by early fall and additional detections possible through October. Trader consensus favoring the 20–34 range reflects these trends plus uncertainty around final reporting lags and weather-driven transmission variability, while lower odds for under 20 or 50-plus outcomes track the current trajectory and typical seasonal patterns.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong